{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:02:45Z","timestamp":1759935765577},"reference-count":18,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.vaccine.2010.09.024","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T08:39:12Z","timestamp":1284799152000},"page":"8043-8045","source":"Crossref","is-referenced-by-count":19,"title":["The role of adjuvants in vaccines for seasonal and pandemic influenza"],"prefix":"10.1016","volume":"28","author":[{"given":"Lorena E.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.vaccine.2010.09.024_bib0005","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.024_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nature Reviews in Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.024_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1440-1711.2005.01319.x","article-title":"ISCOM-based vaccines: the second decade","volume":"83","author":"Sanders","year":"2005","journal-title":"Immunology and Cell Biology"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.024_bib0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/icb.2009.21","article-title":"Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant","volume":"87","author":"Maraskovsky","year":"2009","journal-title":"Immunology and Cell Biology"},{"issue":"15","key":"10.1016\/j.vaccine.2010.09.024_bib0025","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1128\/JVI.00241-09","article-title":"Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization","volume":"83","author":"Middleton","year":"2009","journal-title":"Journal of Virology"},{"issue":"11","key":"10.1016\/j.vaccine.2010.09.024_bib0030","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.185.11.1951","article-title":"Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration","volume":"185","author":"Muhlradt","year":"1997","journal-title":"Journal of Experimental Medicine"},{"issue":"43","key":"10.1016\/j.vaccine.2010.09.024_bib0035","doi-asserted-by":"crossref","first-page":"15440","DOI":"10.1073\/pnas.0406740101","article-title":"A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses","volume":"101","author":"Jackson","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/j.vaccine.2010.09.024_bib0040","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/intimm\/dxl114","article-title":"Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines","volume":"18","author":"Lau","year":"2006","journal-title":"International Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.024_bib0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4049\/jimmunol.171.1.32","article-title":"Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target","volume":"171","author":"Schjetne","year":"2003","journal-title":"Journal of Immunology"},{"issue":"23","key":"10.1016\/j.vaccine.2010.09.024_bib0050","doi-asserted-by":"crossref","first-page":"12388","DOI":"10.1128\/JVI.76.23.12388-12393.2002","article-title":"Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice","volume":"76","author":"Belz","year":"2002","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.024_bib0055","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/eji.200535217","article-title":"Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza","volume":"36","author":"Deliyannis","year":"2006","journal-title":"European Journal of Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.024_bib0060","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.4049\/jimmunol.179.4.2187","article-title":"The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells","volume":"179","author":"Day","year":"2007","journal-title":"Journal of Immunology"},{"issue":"9","key":"10.1016\/j.vaccine.2010.09.024_bib0065","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.76.9.4212-4221.2002","article-title":"Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus","volume":"76","author":"Deliyannis","year":"2002","journal-title":"Journal of Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.024_bib0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1750-2659.2009.00087.x","article-title":"Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenza","volume":"3","author":"Ng","year":"2009","journal-title":"Influenza and Other Respiratory Viruses"},{"key":"10.1016\/j.vaccine.2010.09.024_bib0075","series-title":"Options for the control of influenza VI","first-page":"199","article-title":"Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cell responses in the control of seasonal and pandemic influenza","author":"Brown","year":"2008"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.024_bib0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/icb.2009.16","article-title":"Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes","volume":"87","author":"Brown","year":"2009","journal-title":"Immunology and Cell Biology"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.024_bib0085","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1357-2725(01)00164-9","article-title":"A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2","volume":"34","author":"Seya","year":"2002","journal-title":"International Journal of Biochem Cell Biology"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.024_bib0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2567.2008.02922.x","article-title":"Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells","volume":"126","author":"Dearman","year":"2009","journal-title":"Immunology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T01:21:30Z","timestamp":1544232090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10013344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":18,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0264410X10013344"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}